Last Updated: October 2, 2026

Details for Patent: 9,375,498

Name: Drug Patent Intelligence for US Patent 9375498
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,375,498 protect, and when does it expire?

Patent 9,375,498 protects NETSPOT and is included in one NDA.

This patent has thirty-two patent family members in nineteen countries.

Summary for Patent: 9,375,498

Title:	Process for the preparation of complexes of 68Ga
Abstract:	A process for the preparation of complexes containing 68Ga wherein a buffer formic acid/formate in the presence of compounds capable to sequester metal cations is used in the complexion reaction.
Inventor(s):	Lorenza Fugazza, Maria Azzurra Filannino, Maurizio Franco Mariani
Assignee:	Advanced Accelerator Applications International SA
Application Number:	US14/237,728
Patent Claim Types: see list of patent claims	Compound; Process; Device;

Drugs Protected by US Patent 9,375,498

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Novartis	NETSPOT	gallium dotatate ga-68	POWDER;INTRAVENOUS	208547-001	Jun 1, 2016		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial	Y				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,375,498

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Italy	FI2011A0180	Aug 12, 2011

PCT Information
PCT Filed	August 10, 2012	PCT Application Number:	PCT/EP2012/065659
PCT Publication Date:	February 21, 2013	PCT Publication Number:	WO2013/024013

International Family Members for US Patent 9,375,498

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2012297008	⤷ Start Trial
Brazil	112014003336	⤷ Start Trial
Brazil	122020011908	⤷ Start Trial
Canada	2844145	⤷ Start Trial
Canada	3045484	⤷ Start Trial
China	103889930	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.